Cargando…

Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial

OBJECTIVE: To establish the feasibility of a randomized, placebo-controlled trial to investigate the effect of a specific immunotherapy bacterial lysate OM-89 (Uro-Vaxom(®)) in reducing the frequency of urinary tract infections in people with neurogenic bladder dysfunction. DESIGN: A parallel-group,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wade, Derick T, Cooper, James, Peckham, Nicholas, Belci, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Evaluative Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649953/ https://www.ncbi.nlm.nih.gov/pubmed/32762340 http://dx.doi.org/10.1177/0269215520946065

Ejemplares similares

Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study
por: Wade, Derick, et al.
Publicado: (2019)

Urinary tract infection in the neurogenic bladder
por: Vigil, Humberto R., et al.
Publicado: (2016)

Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction
por: Konstantinidis, Charalampos, et al.
Publicado: (2016)

Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction
por: Johnson, E. U., et al.
Publicado: (2013)

Dual-task walking and automaticity after Stroke: Insights from a secondary analysis and imaging sub-study of a randomised controlled trial
por: Collett, Johnny, et al.
Publicado: (2021)

Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction
por: Pannek, Jürgen, et al.
Publicado: (2017)

Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
por: Pannek, Jürgen, et al.
Publicado: (2017)

Molecular Characterization of Non-Neurogenic and Neurogenic Lower Urinary Tract Dysfunction (LUTD) in SCI-Induced and Partial Bladder Outlet Obstruction Mouse Models
por: von Siebenthal, Michelle, et al.
Publicado: (2023)

A Study of DNA Methylation of Bladder Cancer Biomarkers in the Urine of Patients with Neurogenic Lower Urinary Tract Dysfunction
por: Koukourikis, Periklis, et al.
Publicado: (2023)

Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis
por: Jaekel, Anke K., et al.
Publicado: (2022)

Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023)

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
por: Dhillon, Sohita
Publicado: (2018)

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs
por: Balaji, Aanika, et al.
Publicado: (2020)

The concerns of mechanical upper urinary tract obstruction in neurogenic lower urinary tract dysfunction: Beyond augmentation cystoplasty
por: Zhou, Zhonghan, et al.
Publicado: (2023)

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction
por: Fragalà, Eugenia, et al.
Publicado: (2015)

Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders
por: Forster, Catherine S, et al.
Publicado: (2019)

New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction
por: Miyazato, Minoru, et al.
Publicado: (2017)

Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020)

Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis
por: Beck, Janina, et al.
Publicado: (2022)

Posing as Ascites: A Case Report on Neurogenic Lower Urinary Tract Dysfunction
por: Sousa, Luís Carlos, et al.
Publicado: (2023)

A Case of Recurrent Urinary Tract Infections With Neurogenic Bladder Due to Spinal Tumors
por: NASERI, Mitra, et al.
Publicado: (2021)

1432. Patient-Reported Urinary Tract Infection Symptoms Among Veterans with Neurogenic Bladder
por: Fitzpatrick, Margaret A, et al.
Publicado: (2021)

A nomogram for predicting upper urinary tract damage risk in children with neurogenic bladder
por: Li, Qi, et al.
Publicado: (2022)

Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction
por: Knüpfer, Stephanie C, et al.
Publicado: (2014)

The effects of small-needle-knife therapy on pain and mobility from knee osteoarthritis: a pilot randomized-controlled study
por: Zhu, Junchen, et al.
Publicado: (2020)

Contractile and Structural Properties of Detrusor from Children with Neurogenic Lower Urinary Tract Dysfunction
por: Johal, Navroop, et al.
Publicado: (2021)

Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children
por: Planta, Dafni, et al.
Publicado: (2023)

Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury
por: Shimizu, Nobutaka, et al.
Publicado: (2023)

Urinary Tract Infection Prophylaxis in Children with Neurogenic Bladder with Cranberry Capsules: Randomized Controlled Trial
por: Mutlu, Hatice, et al.
Publicado: (2012)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
por: Pellegrino, Chiara, et al.
Publicado: (2023)

Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections
por: Kennelly, Michael, et al.
Publicado: (2019)

Application of data mining techniques to explore predictors of upper urinary tract damage in patients with neurogenic bladder
por: Fang, H., et al.
Publicado: (2017)

Perceptions, experiences, and beliefs regarding urinary tract infections in patients with neurogenic bladder: A qualitative study
por: Fitzpatrick, Margaret A., et al.
Publicado: (2023)

Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
por: Sammer, Ulla, et al.
Publicado: (2015)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Urine Biomarkers in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review
por: Koukourikis, Periklis, et al.
Publicado: (2023)

Optogenetic Modulation of Urinary Bladder Contraction for Lower Urinary Tract Dysfunction
por: Park, Jae Hong, et al.
Publicado: (2017)

Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study
por: Zhou, Liqiong, et al.
Publicado: (2022)

Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2021)

New grading system for upper urinary tract dilation using magnetic resonance urography in patients with Neurogenic Bladder
por: Liao, Limin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l2u2qratg5ihebb6c0v95jk1ur